Stimulant use disorder is a clinical diagnosis describing a pattern of stimulant drug use that causes significant problems in a person’s life and becomes difficult to control despite those consequences. In 2023, about 4.3 million people aged 12 or older in the United States (1.5% of the population) had this disorder. It covers a range of substances, from illegal drugs like cocaine and methamphetamine to prescription medications like those used for ADHD.
Which Drugs Are Considered Stimulants
The disorder applies to any central nervous system stimulant that speeds up brain activity and produces feelings of energy, alertness, or euphoria. The most commonly involved substances are cocaine (including crack cocaine), methamphetamine, and prescription amphetamines and methylphenidate. Prescription stimulants are widely used for ADHD, narcolepsy, and occasionally weight management, and while most people who take them as prescribed never develop a disorder, misuse can lead to one.
Methamphetamine is far more potent and longer-lasting than cocaine. Its effects last 10 to 12 hours, compared to cocaine’s half-hour to two-hour window. That longer duration contributes to extended periods of wakefulness, greater cardiovascular strain, and a higher risk of psychotic symptoms during binges.
How It’s Diagnosed
The DSM-5 uses a single list of 11 possible symptoms to evaluate stimulant use disorder. You don’t need to have all of them. Meeting two or three criteria within a 12-month period qualifies as a mild disorder, four or five as moderate, and six or more as severe. The criteria capture a wide range of behaviors and experiences:
- Using more of the substance, or using it for longer, than you intended
- Wanting to cut down or stop but being unable to
- Spending a large amount of time obtaining, using, or recovering from the substance
- Experiencing strong cravings or urges to use
- Failing to meet responsibilities at work, school, or home because of use
- Continuing to use despite social or relationship problems it causes
- Giving up important activities or hobbies
- Using in situations that are physically dangerous
- Continuing to use despite knowing it’s causing physical or psychological harm
- Needing more of the substance to get the same effect (tolerance)
- Experiencing withdrawal symptoms when use stops
The diagnosis treats substance problems as a spectrum rather than an all-or-nothing condition. Someone who meets two criteria has a real but milder version of the same disorder as someone meeting nine.
What Stimulants Do to the Brain
Stimulants hijack the brain’s reward system, a circuit that normally reinforces survival behaviors like eating and social bonding. This circuit relies on dopamine, a chemical messenger that signals pleasure and motivation. Under normal conditions, a neuron releases dopamine into the gap between itself and a neighboring neuron, the dopamine delivers its signal, and then it’s recycled back into the original neuron through a transporter protein.
Cocaine works by physically blocking that recycling process. Dopamine stays in the gap longer than it should, continuing to stimulate the receiving neuron and producing an exaggerated sense of reward. Methamphetamine does this too, but it also forces neurons to release extra dopamine directly, flooding the system from both directions. Prescription stimulants like methylphenidate block the dopamine transporter in a similar way to cocaine, though at therapeutic doses the effect is much more gradual and controlled.
Over time, the brain adapts to this excess dopamine by becoming less sensitive to it. Activities that once felt enjoyable lose their appeal, and the person needs increasing amounts of the drug just to feel normal. This is the biological foundation of both tolerance and the persistent low mood that characterizes withdrawal.
Withdrawal: What Happens When You Stop
Stimulant withdrawal doesn’t produce the dramatic physical dangers of alcohol or opioid withdrawal, but it can be intensely unpleasant and is a major driver of relapse. It unfolds in three phases.
The acute phase, often called the “crash,” begins within hours of the last dose and peaks around days two to three. During this period, you can expect deep fatigue, prolonged sleep (sometimes 12 hours or more), depression, anxiety, irritability, body aches, headaches, and strong cravings. The worst of these symptoms typically resolve within four to seven days.
From roughly weeks two through four, most withdrawal symptoms continue to ease. Mood and energy gradually return toward baseline, and many people can begin resuming daily routines. Cravings drop from their first-week peak but can still surge unpredictably.
After about a month, a subtler phase sets in that can last for weeks or even months. People in this stage often describe a kind of cognitive dullness, difficulty with memory and decision-making, lingering mild depression, and occasional cravings. These symptoms reflect the slow process of the brain’s reward system recalibrating after sustained overstimulation.
Physical and Psychological Health Effects
Chronic stimulant use takes a measurable toll on the heart. Stimulants elevate blood pressure by making the heart beat faster and harder, and over time this can lead to structural damage. A study presented to the American College of Cardiology found that even people taking prescription stimulants for ADHD were 57% more likely to develop cardiomyopathy (weakened heart muscle) after eight years compared to those not taking stimulants. The absolute risk remained small, with less than 1% of long-term users affected, but the finding underscores that cardiovascular strain is a real consequence of prolonged stimulant exposure, whether prescription or illicit.
Stimulant-induced psychosis is one of the more alarming psychological effects. It most commonly appears during heavy or prolonged use, particularly with methamphetamine, and involves paranoid delusions, auditory or tactile hallucinations, agitation, and sometimes violent behavior. For most people, these symptoms resolve within about a week of stopping the drug without needing specific treatment. However, roughly 16 to 17% of people who experience stimulant psychosis continue to have symptoms after one to three months of abstinence. In some cases, what begins as a drug-induced episode eventually “converts” into a primary psychotic disorder that persists even without further drug use.
Recognizing a Stimulant Overdose
Stimulant overdoses look different from opioid overdoses. Instead of slowing the body down, a stimulant overdose revs it dangerously high. Warning signs include rapid heartbeat or irregular heart rhythm, chest pain, confusion, extreme agitation, tremors, nausea, overheating, and excessive sweating. In severe cases, a person’s blood pressure and body temperature climb rapidly, leading to delirium and seizures.
Call 911 immediately if someone loses consciousness, stops breathing, has a seizure lasting longer than five minutes, shows signs of stroke (sudden numbness, severe headache, blurred vision, loss of coordination), or shows signs of a heart attack (chest pressure, pain radiating to the jaw or arms, shortness of breath). There is no equivalent of naloxone for stimulant overdoses, so emergency medical care is the only option.
Treatment Options
One of the biggest challenges in treating stimulant use disorder is the lack of medication. No drug has received FDA approval specifically for this condition, unlike opioid or alcohol use disorders, which have several medication options. The FDA has publicly acknowledged this gap and taken steps to encourage the development of new therapies, but for now, treatment relies primarily on behavioral approaches.
The most effective behavioral treatment is contingency management, which works on a straightforward principle: you receive tangible rewards for providing drug-free urine samples. These rewards might be vouchers, prizes, or small cash incentives that increase in value the longer you maintain abstinence. A meta-analysis of 23 studies found that contingency management produces the largest effect size of any psychosocial treatment for reducing drug use, and that longer treatment periods significantly improve the odds of staying abstinent up to a year later. About half of programs use a prize-drawing system, while the other half use vouchers. Most programs escalate the reward value over time, reinforcing sustained progress.
Cognitive behavioral therapy is also commonly used, helping people identify the triggers, thought patterns, and situations that lead to use, and building practical skills for managing cravings. Many treatment programs combine both approaches.
ADHD and Stimulant Use Disorder
The relationship between ADHD and stimulant use disorder is complicated. Adults with ADHD develop substance use disorders at two to three times the rate of the general population, and some of that risk involves the very stimulant medications prescribed to treat their ADHD. This creates a clinical balancing act: untreated ADHD itself is a risk factor for substance problems, but stimulant treatment carries its own risks of misuse.
When both conditions are present, guidelines recommend prioritizing non-stimulant ADHD medications when possible. If stimulants are needed, long-acting formulations are preferred over immediate-release versions because they produce a slower, steadier effect that’s less likely to trigger the reward surge associated with misuse. Additional safeguards include limiting the number of pills dispensed at one time, regular drug testing to monitor for misuse, and combining medication with psychosocial treatment. These strategies aim to manage ADHD symptoms effectively while minimizing the risk of fueling a stimulant use disorder.